PATH: Clinical Trials

3 trials sponsored by PATH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 3
Phase 11Recruiting 1

Follow PATH: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 2 (nOPV2), Placebo (Sterile Water) - Poliomyelitis
Phase 2RecruitingPATH6752025-11-112026-01-09
Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines
Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2), Novel oral poliomyelitis vaccine type 3 (nOPV3) - Poliomyelitis
Phase 1 / Phase 2RecruitingPATH24002024-11-202025-06-03
Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama
Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3), Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3) - Poliomyelitis
Phase 2RecruitingPATH15322023-12-052026-05-11

Conditions studied

Poliomyelitis (3)

Countries

Panama (2)  ·  Bangladesh (1)

Top investigators

Xavier Saez Llorens, MD (1)  ·  Xavier Saez-Llorens, MD (1)